NCT03591913View on ClinicalTrials.gov

Preoperative and Postoperative Sublingual Misoprostol for Prevention of Postpartum Blood Loss in Cesarean Section

PHASE4CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

February 1, 2018

Primary Completion Date

August 1, 2018

Study Completion Date

September 1, 2018

Conditions
Postpartum Hemorrhage
Interventions
DRUG

Misoprostol

Oral tablets

Trial Locations (1)

002

Ahmed Abbas, Assiut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03591913 - Preoperative and Postoperative Sublingual Misoprostol for Prevention of Postpartum Blood Loss in Cesarean Section | Biotech Hunter | Biotech Hunter